1. Home
  2. RGNX vs YRD Comparison

RGNX vs YRD Comparison

Compare RGNX & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • YRD
  • Stock Information
  • Founded
  • RGNX 2008
  • YRD 2012
  • Country
  • RGNX United States
  • YRD China
  • Employees
  • RGNX N/A
  • YRD N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • YRD Finance: Consumer Services
  • Sector
  • RGNX Health Care
  • YRD Finance
  • Exchange
  • RGNX Nasdaq
  • YRD Nasdaq
  • Market Cap
  • RGNX 387.0M
  • YRD 411.2M
  • IPO Year
  • RGNX 2015
  • YRD 2015
  • Fundamental
  • Price
  • RGNX $6.76
  • YRD $7.29
  • Analyst Decision
  • RGNX Strong Buy
  • YRD
  • Analyst Count
  • RGNX 9
  • YRD 0
  • Target Price
  • RGNX $32.89
  • YRD N/A
  • AVG Volume (30 Days)
  • RGNX 1.0M
  • YRD 213.0K
  • Earning Date
  • RGNX 05-07-2025
  • YRD 03-20-2025
  • Dividend Yield
  • RGNX N/A
  • YRD 5.39%
  • EPS Growth
  • RGNX N/A
  • YRD N/A
  • EPS
  • RGNX N/A
  • YRD 2.48
  • Revenue
  • RGNX $83,328,000.00
  • YRD $795,426,969.00
  • Revenue This Year
  • RGNX $285.14
  • YRD N/A
  • Revenue Next Year
  • RGNX N/A
  • YRD N/A
  • P/E Ratio
  • RGNX N/A
  • YRD $2.77
  • Revenue Growth
  • RGNX N/A
  • YRD 18.59
  • 52 Week Low
  • RGNX $5.62
  • YRD $4.12
  • 52 Week High
  • RGNX $21.19
  • YRD $9.20
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 41.59
  • YRD 53.56
  • Support Level
  • RGNX $7.96
  • YRD $6.54
  • Resistance Level
  • RGNX $8.35
  • YRD $7.65
  • Average True Range (ATR)
  • RGNX 0.65
  • YRD 0.54
  • MACD
  • RGNX -0.04
  • YRD -0.06
  • Stochastic Oscillator
  • RGNX 13.21
  • YRD 40.08

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an advanced, AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

Share on Social Networks: